Blue Horizon International AG is a global healthcare consulting and innovation company that specializes in adult and pediatric stem cell-based therapies and regenerative medicine. The company focuses on scientific research, education, clinical care, and philanthropy, collaborating with international physicians, research institutions, and regulated facilities. It provides investigational cellular and exosome products evaluated through clinical studies conducted under institutional review board approvals.
Subscribe to see Blue Horizon International AG’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Blue Horizon International AG is a healthcare & biotechnology company headquartered in United States. Its most recent funding round raised $2.5M in August 2015. Xcout tracks 4 named people at Blue Horizon International AG, including Doreen Santora, RN MHA (Chief Executive Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Blue Horizon International AG's closest competitors — see the full list of competitors and alternatives →
Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.
CHA Health Systems and CHA Bio Group operate a global network of hospitals, fertility centers, and biotechnology companies focusing on medical services, research, and cell and gene therapy.
CellSource Co., Ltd. operates within both the regenerative medicine and consumer product sectors. Among its offerings is Signalift, an anti-aging solution. The company, which was established in 2015, is headquartered in Tokyo, Japan.
Kadimastem Ltd. is a clinical-stage cell therapy company headquartered in Ness Ziona, Israel, focused on developing advanced cell-based therapeutic treatments.
An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.